There are many proven health benefits to weight loss, but trying to lose weight without the help of a knowledgeable physician can be difficult. At Hybrid Medical Solution, we now offer Semaglutide including Wegovy, Ozemic, and Rybelsus, a new prescription weight loss medication that can help you effectively lose weight and improve your health markers. Schedule an appointment with our providers today to learn more.
Semaglutide medication proven to aid weight loss through a once-weekly injection. It belongs to a class of medications called GLP-1 RAs, or glucagon-like peptide-1 receptor agonists. These types of medications mimic the GLP-1 hormone, a hormone involved in the digestive process and insulin response. Although semaglutide has been in use for over 15 years as a way to treat type-2 diabetes, it has recently been utilized to manage weight and aid patients in the weight loss process.
In clinical studies, semaglutide has shown significant promise as a way to reduce excess weight, with patients using semaglutide achieving at least a 5% reduction in weight. In fact, some studies have shown as much as 6% weight reduction at 3 months of use and 11% weight reduction at 6 months. With semaglutide, you can more effectively reduce your weight and see noticeable results from your medical diet and exercise regimen.
Semaglutide is indicated for patients who have a body mass index (BMI) of 30 or higher, or who have a BMI of 27 or higher with at least one weight-related condition such as diabetes, high blood pressure, or high cholesterol. Some medical conditions may indicate that you should avoid semaglutide. Our providers will take a detailed medical history and determine whether this option is ideal for your weight loss efforts.
“ Very thorough and knowledgeable, focuses on preventive medicine which is rare and much appreciated. ”
“ Very diligent and thorough in their care of the patients. My entire family goes here. The PAs are kind and comprehensive in their consultations. Great practice! ”
“ First visit to the office. Everyone was friendly. Liked the Doctor very much! ”
Semaglutide works by mimicking the GLP-1 hormone in the digestive system. There are two results of this process – firstly, GLP-1 plays a role in producing insulin and reducing blood sugar levels after eating. Secondly, GLP-1 interacts with the brain and digestive system to signal feelings of fullness, reducing your food intake. By supplementing GLP-1 and promoting feelings of satisfaction in the digestive system, it can allow you to more easily stick to your diet and reduce weight. As a result of this process, semaglutide is also associated with a reduction in weight-related risks like cancer, diabetes, or heart disease in people who are overweight or obese.
Semaglutide is a once-weekly injection that you administer to yourself at home. Your provider will prescribe a supply of doses and regularly check in to ensure that you see results from your diet and exercise efforts. Over the following weeks and months, you may begin to see noticeable changes in your weight.
Semaglutide may take at least eight weeks of consistent use to begin producing results. When used for several months along with daily activity and eating nutritious foods, it can cause weight loss of 5% or more of your body weight, helping you reduce your risk of weight-related conditions. Our providers can give you a better estimate of what results you can expect from semaglutide when paired with an effective diet and exercise regimen.
At Hybrid Medical Solution, we now offer semaglutide as a way to help you manage your weight. To meet with our providers and get started, contact our Boca Raton, FL office by calling or filling out our online form.
Ghusn W, De la Rosa A, Sacoto D, Cifuentes L, Campos A, Feris F, Hurtado MD, Acosta A. Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity. JAMA Netw Open. 2022 Sep 1;5(9):e2231982. doi: 10.1001/jamanetworkopen.2022.31982. PMID: 36121652; PMCID: PMC9486455.
Wilding, J. P., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine. https://doi.org/10.1056/NEJMoa2032183